Piramal Pharma Limited (NSE:PPLPHARMA)

Piramal Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 18, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	280,711	297,962	170,528	81,683	-	-
Market Cap Growth	74.73%	74.73%	108.77%	-	-	-
Enterprise Value	324,065	341,742	209,922	130,128	-	-
Last Close Price	211.18	224.60	128.72	66.76	-	-
PE Ratio	308.03	326.96	956.95	-	-	-
Forward PE	153.52	70.54	42.33	40.39	-	-
PS Ratio	3.07	3.26	2.09	1.15	-	-
PB Ratio	3.45	3.67	2.15	1.21	-	-
P/TBV Ratio	6.95	7.38	4.71	3.51	-	-
P/FCF Ratio	123.16	130.73	58.30	-	-	-
P/OCF Ratio	31.46	33.39	16.98	16.88	-	-
PEG Ratio	0.91	1.58	1.58	1.35	-	-
EV/Sales Ratio	3.54	3.73	2.57	1.84	-	-
EV/EBITDA Ratio	21.35	24.34	18.43	22.58	-	-
EV/EBIT Ratio	46.20	54.38	45.62	-	-	-
EV/FCF Ratio	142.18	149.94	71.77	-	-	-
Debt / Equity Ratio	0.60	0.60	0.60	0.83	0.62	0.54
Debt / EBITDA Ratio	3.36	3.36	4.00	9.21	3.63	2.30
Debt / FCF Ratio	21.31	21.31	16.10	-	-	-
Asset Turnover	0.59	0.59	0.55	0.52	0.57	-
Inventory Turnover	1.44	1.44	1.69	1.94	1.87	-
Quick Ratio	0.76	0.76	0.61	0.64	0.69	0.82
Current Ratio	1.54	1.54	1.25	1.26	1.34	1.47
Return on Equity (ROE)	1.14%	1.14%	0.24%	-2.77%	6.11%	-
Return on Assets (ROA)	2.54%	2.54%	1.93%	-0.20%	2.96%	-
Return on Capital (ROIC)	3.07%	3.07%	2.30%	-0.24%	3.60%	-
Return on Capital Employed (ROCE)	5.30%	5.30%	4.20%	-	5.70%	10.50%
Earnings Yield	0.32%	0.31%	0.10%	-2.28%	-	-
FCF Yield	0.81%	0.77%	1.71%	-5.89%	-	-
Dividend Yield	0.07%	0.06%	0.08%	-	-	-
Payout Ratio	20.59%	15.88%	-	-	13.30%	-
Buyback Yield / Dilution	-4.41%	-4.41%	-7.85%	-0.95%	-87.83%	-
Total Shareholder Return	-4.35%	-4.35%	-7.76%	-0.95%	-87.83%	-

Updated Jan 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.